“Lung cancer is a disease where uncontrolled cell growth occurs in the lung leading to tumours,” explains Dr Jenny Messenger, ...

The mixed results showed that ivonescimab plus chemotherapy reduced the risk of disease progression or death by 48% compared to chemotherapy alone. Summit Therapeutics announced its intention to file ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Conavi Medical Corp. ("Conavi Medical" or the "Company"), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally ...

The envisioned flow cytometry test will help to predict patient response to immunotherapies for five cancer indications.

A recently-approved treatment could take a BiTE out of small cell lung cancer by using a person's own body to fight back.

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

Researchers led by Université de Montréal pathology and cell-biology professor Marc Therrien have identified major structural ...

Antibody-drug conjugates have become a “choose your own adventure” tool in pharma R&D. Due to their versatility, the ...

A new study employing novel single-cell multimodal data revealed key insights into the tumor microenvironment predictive of NSCLC treatment response.

Cofactor Genomics announced the latest validation results for OncoPrism ®, Cofactor’s breakthrough RNA-based diagnostic approach at the RNA Society’s 30th Annual Meeting. The talk, presented by Dr.